Inflammatory mediators leading to protein misfolding and uncompetitive/fast off-rate drug therapy for neurodegenerative disorders.
Level 5 - mechanism / opinion, no new human data
Narrative review and mechanistic synthesis of pharmacological concepts without new human clinical trial data.
PubMed 17678953 · doi:10.1016/S0074-7742(07)82001-0
What was done
This narrative review summarizes mechanisms by which excitotoxicity and inflammatory mediators (specifically nitric oxide and reactive oxygen species) trigger aberrant S-nitrosylation of proteins such as protein disulfide isomerase (PDI) and parkin, leading to protein misfolding in neurodegenerative disorders (e.g., Alzheimer's disease and Parkinson's disease). It also reviews the pharmacodynamic rationale for uncompetitive, fast off-rate NMDA receptor channel blockers, including memantine and second-generation NitroMemantines.
What was found
The abstract reports no quantitative numerical data or statistical metrics. It describes how S-nitrosylation of PDI impairs endoplasmic reticulum protein folding, leading to neuronal injury, and notes that pathological levels of S-nitrosylated PDI occur in human Alzheimer's and Parkinson's disease brains. It highlights that memantine's uncompetitive open-channel blockade and rapid off-rate allow it to prevent excitotoxic damage without interrupting normal synaptic transmission, leading to its clinical tolerability and regulatory approvals.
Why it matters
The paper outlines a direct biochemical connection between excitotoxicity, aberrant S-nitrosylation, and protein misfolding, while providing a mechanistic explanation for why fast off-rate NMDA antagonists succeed therapeutically where high-affinity blockers fail.
Limits
The abstract describes a narrative review and expert perspective; it presents no new primary experimental data, clinical trial metrics, or systematic synthesis methodology.
Cited by
- supports Excitotoxicity is an established pathological factor in stroke, traumatic brain injury, ALS, Parkinson's disease, and Alzheimer's disease.